Grifols (GRFS) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

GRFS Grifols

Watchlist

7.600
-0.250-3.18%

Close Jan 8 16:00 ET

5.17BMarket Cap30.65P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Grifols Closes Private Placement for EUR1.3 Billion Notes
MT NewswiresDec 23, 2024 04:44 ET
Moody's Assigns Ratings, Positive Outlook on Grifols
MT NewswiresDec 18, 2024 08:11 ET
Fitch Affirms Grifols Rating on Forecast of EBITDA Growth
MT NewswiresDec 17, 2024 23:47 ET
Grifols Price Target Lowered to EUR 15.40 From EUR 15.50 at Berenberg
TipRanksDec 16, 2024 12:15 ET
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading
MT NewswiresDec 16, 2024 11:10 ET
Grifols (0RDU) Receives a Buy From Berenberg Bank
TipRanksDec 16, 2024 02:17 ET · Ratings

Comments

Trytosaveabit

Oct 29, 2024 07:12

News

$Grifols (GRFS.US)$ Grifols Receives FDA Approval To Treat Surgical Bleeding In Pediatric Patients With Its Fibrin Sealant Solution
Benzinga· 3 mins ago

Trytosaveabit

Oct 3, 2024 07:12

If any seen that for the 40 seconds it was posted!

$Grifols (GRFS.US)$ I removed the post because i think the PR was tagged to the wrong ticker by the NEWS OUTLETT! And i want to be more safe and check a bit more!

Trytosaveabit

Aug 21, 2024 03:57

A bit added to older PR ( seeking backing ) is the new!

$Grifols (GRFS.US)$ Investing.com -- Shares of Grifols SA (BME:GRLS) (NASDAQ:GRFS) rose on Wednesday after Bloomberg News reported that Brookfield Asset Management (TSX:BAM) is seeking bank backing for up to €9.5 billion in debt to facilitate its potential take-private acquisition of the Spanish pharmaceutical producer

Trytosaveabit

Jul 29, 2024 07:04

News

$Grifols (GRFS.US)$ Benzinga· 2 mins ago
FDA Approves Expanded Label For Grifols' XEMBIFY, The First 20% SCIg For Treatment-Naïve Patients With Primary Humoral Immunodeficiencies; Approval Includes Biweekly Dosing Following Positive Phase 4 Data, Enhancing Flexibility And Convenience For Patients

Kevin Travers

Jul 8, 2024 09:50

Columns Fresh Highs Before Flat Trading, Last Week Before Q2 Earnings | Herd on Wall Street

Morning traders, it is the final slow week before a new earnings season begins Thurday with $Delta Air Lines (DAL.US)$ and properly on Friday with $JPMorgan (JPM.US)$.
Welcome to the end of the dog days of summer for a while; my name is Kevin Travers, and here are stories from the moomoo herd on Wall Street today.
$Intel (INTC.US)$ traded higher after the firm said it had bypassed Vietnam for a $3.3B project and in...

Live Stock Financial Podcast. What are you watching on the market?

Heat List

Overall

No Data